Cargando…

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma

BRAF inhibitors (BRAFi) selectively target oncogenic BRAF(V600E/K) and are effective in 80% of advanced cutaneous malignant melanoma cases carrying the V600 mutation. However, the development of drug resistance limits their clinical efficacy. Better characterization of the underlying molecular proce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidarsdottir, Linda, Azimi, Alireza, Das, Ishani, Sigvaldadottir, Ingibjorg, Suryo Rahmanto, Aldwin, Petri, Andreas, Kauppinen, Sakari, Ingvar, Christian, Jönsson, Göran, Olsson, Håkan, Frostvik Stolt, Marianne, Tuominen, Rainer, Sangfelt, Olle, Pokrovskaja Tamm, Katja, Hansson, Johan, Grandér, Dan, Egyházi Brage, Suzanne, Johnsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155038/ https://www.ncbi.nlm.nih.gov/pubmed/34040017 http://dx.doi.org/10.1038/s41598-021-89389-9

Ejemplares similares

Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib
por: Vidarsdottir, Linda, et al.
Publicado: (2020)

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
por: Falkenius, Johan, et al.
Publicado: (2017)

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance
por: Azimi, A, et al.
Publicado: (2014)

K63-linked ubiquitylation induces global sequestration of mitochondria
por: Richard, Thibaud J. C., et al.
Publicado: (2020)

Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020)

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
por: Azimi, Alireza, et al.
Publicado: (2017)

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
por: Hjerpe, Elisabet, et al.
Publicado: (2013)

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
por: Brunner, Andrä, et al.
Publicado: (2020)

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
por: Costa Svedman, Fernanda, et al.
Publicado: (2022)

Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011)

Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
por: Das, Ishani, et al.
Publicado: (2019)

A pseudogene long noncoding RNA network regulates PTEN transcription and translation in human cells
por: Johnsson, Per, et al.
Publicado: (2013)

TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells
por: Kim, Patrick Y., et al.
Publicado: (2013)

An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a
por: Serviss, Jason T., et al.
Publicado: (2018)

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
por: Tobin, N. P., et al.
Publicado: (2015)

Measuring single‐cell protein secretion in immunology: Technologies, advances, and applications
por: Bucheli, Olivia T. M., et al.
Publicado: (2021)

FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma
por: Suryo Rahmanto, Aldwin, et al.
Publicado: (2016)

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

PTENP1 is a ceRNA for PTEN: it’s CRISPR clear
por: Vitiello, Marianna, et al.
Publicado: (2020)

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer
por: Akhoondi, Shahab, et al.
Publicado: (2010)

Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway
por: Arabi, Azadeh, et al.
Publicado: (2012)

Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro
por: Hu, Su, et al.
Publicado: (2018)

Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population
por: Ge, Yugang, et al.
Publicado: (2017)

CDK-mediated activation of the SCF(FBXO28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer
por: Cepeda, Diana, et al.
Publicado: (2013)

AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
por: Zheng, Rui, et al.
Publicado: (2018)

Methylation of the PTENP1 pseudogene as potential epigenetic marker of age-related changes in human endometrium
por: Kovalenko, Tatyana F., et al.
Publicado: (2021)

PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics
por: Travis, Glena, et al.
Publicado: (2023)

Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC
por: Liu, Jiannan, et al.
Publicado: (2017)

Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
por: Cao, Liang-qi, et al.
Publicado: (2019)

A review on the role of PTENP1 in human disorders with an especial focus on tumor suppressor role of this lncRNA
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Identification of novel small molecules that inhibit STAT3-dependent transcription and function
por: Kolosenko, Iryna, et al.
Publicado: (2017)

An emerging role for long non-coding RNAs in cancer metastasis
por: Serviss, Jason T., et al.
Publicado: (2014)

PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis
por: Gong, Tuotuo, et al.
Publicado: (2017)

Correction to: Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
por: Cao, Liang-qi, et al.
Publicado: (2020)

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
por: Dyczynski, Matheus, et al.
Publicado: (2018)

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death
por: Busker, S., et al.
Publicado: (2020)

Inhibition of microRNA function by antimiR oligonucleotides
por: Stenvang, Jan, et al.
Publicado: (2012)

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy
por: Haddadi, Nahal, et al.
Publicado: (2018)

BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression
por: Liu, Shu-Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7979itoqmbj4dds6bu85a3g0fd